Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 120   

Articles published

GSK 1,633.36 -25.14 (-1.52%)
price chart
GlaxoSmithKline Plc (NYSE:GSK) Unveils Take 5 for Meningitis
GlaxoSmithKline Plc (NYSE:GSK) (GSK) has introduced Take 5 for Meningitis, an educational campaign that seeks to promote meningitis awareness.
Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?
AstraZeneca(LSE: AZN) and GlaxoSmithKline(LSE: GSK) are two companies that have benefitted from this trend. Indeed, since Brexit shares in Astra have gained a staggering 32% and Glaxo's shares have gained 19.4%, both outperforming the wider FTSE ...
GlaxoSmithKline PLC (NYSE:GSK) Updated Price Targets
08/17/2016 - GlaxoSmithKline PLC had its “hold” rating reiterated by analysts at Shore Capital Stockbrokers. 08/08/2016 - GlaxoSmithKline PLC had its “buy” rating reiterated by analysts at Citigroup. 08/02/2016 - GlaxoSmithKline PLC had its “buy ...
Short Interest Update on GlaxoSmithKline PLC (GSK)  Trade Calls
Glaxosmithkline Plc (NYSE:GSK) Shorted Shares Increased By 7.62%  Press Telegraph
Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis ...
Switzerland-based Novartis recently completed a three-part deal in which it sold its vaccine business to GlaxoSmithKline plc (ADR) (NYSE: GSK), bought the Glaxo's oncology business, and merged its consumer healthcare business in a JV with the Glaxo ...
Should you buy GlaxoSmithKline plc after today's results?
GlaxoSmithkline (LSE: GSK) has suffered four years of falling earnings as, along with FTSE 100 competitor AstraZeneca, it faced the loss of patents on some key drugs and a resulting increase in competition from generic alternatives.
Glaxo's Earnings Beat Estimates as New Product Sales Double  Bloomberg
GlaxoSmithKline plc 1.5% Potential Upside Indicated by Cantor Fitzgerald
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'HOLD' today by analysts at Cantor Fitzgerald.
Cantor Fitzgerald Analyst Reaffirmed GBX 1700.00 Price Target on ...  Consumer Eagle
A report released earlier today by Cantor Fitzgerald about (LON:GSK ...  Breaking Finance News
GlaxoSmithKline plc (GSK) Receives "Neutral" Rating from JPMorgan Chase & Co.
GlaxoSmithKline plc logo JPMorgan Chase & Co. reiterated their neutral rating on shares of GlaxoSmithKline plc (LON:GSK) in a report released on Tuesday morning.
A statement released today by JP Morgan Cazenove about GlaxoSmithKline PLC ...  Breaking Finance News
GlaxoSmithKline PLC (LON:GSK) Stock Neutral Rating Maintained at JP Morgan ...  Consumer Eagle
GlaxoSmithKline plc (ADR)(GSK) and Alphabet Inc (GOOGL) Team Up for Joint Venture
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Alphabet Inc's (NASDAQ:GOOGL) Verily Life Sciences, formerly known as Google Life Sciences, come together to form a new joint venture.
GlaxosmithKline teams up with Google sister firm in bioelectronics venture  Proactive Investors UK
Glaxo, Alphabet Form Venture to Make Bioelectronic Medicines  Bloomberg
Is it too late to buy GlaxoSmithKline plc, Glencore plc and Royal Bank of ...
Medical ace GlaxoSmithKline(LSE: GSK) has taken off in the weeks following the EU referendum, the universal and evergreen nature of drugs demand making the firm a brilliant safe haven.
Shire PLC Lags GlaxoSmithKline plc, AstraZeneca plc, Pfizer Inc. And Johnson ...
This is less than the gains made by global sector peers such as GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN), Pfizer Inc. (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ).